Concepedia

Jennifer Mataraza

JM

Statistics

Publications

20

Citations

2K

H-Index

18

Active since

2003

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Brigham and Women's Hospital

Harvard University

Jennifer Mataraza is an author at Novartis (Switzerland) specializing in medicine, cancer immunotherapy, and oncology.

Publications per year

2003–2023

20

Publications

20

Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing

Dong Cai, Jennifer Mataraza, Zheng‐Hong Qin et al. · Nature Methods · 2005 · 554 citations

Natural Sciences, Biomedical Engineering, Pharmaceutics +16

Antigen receptor–mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth

Cheryl A. Doughty, Blair F. Bleiman, Dean J. Wagner et al. · Blood · 2006 · 375 citations · Full text

Life Sciences, Biochemistry, Immunology +17

IQGAP1 Promotes Cell Motility and Invasion

Jennifer Mataraza, Michael W. Briggs, Zhigang Li et al. · Journal of Biological Chemistry · 2003 · 207 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

IQGAP1 Stimulates Proliferation and Enhances Tumorigenesis of Human Breast Epithelial Cells

Lorraine Jadeski, Jennifer Mataraza, Ha‐Won Jeong et al. · Journal of Biological Chemistry · 2007 · 135 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

Michael Dickinson, Pere Barba, Ulrich Jäger et al. · Cancer Discovery · 2023 · 121 citations · Full text

Medicine, Hematology, Oncology +17

1–5 of 20